« Back to Record
Citation APA

Roufosse, F., Goldman, M., & Cogan, E. (2006). Hypereosinophilic syndromes: a novel therapeutic indication for tyrosine kinase inhibitors and IL-5 antagonists. Drug Discovery Today: Therapeutic Strategies, 3(1) , 55-61.


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/20649

Roufosse, F., Goldman, M., & Cogan, E. (2006). Hypereosinophilic syndromes: a novel therapeutic indication for tyrosine kinase inhibitors and IL-5 antagonists. Drug Discovery Today: Therapeutic Strategies, 3(1) , 55-61.